- CA$362.82m
- CA$353.44m
- CA$34.22m
- 74
- 13
- 82
- 57
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.95 | 7.42 | 15.5 | 23.7 | 34.2 |
Cost of Revenue | |||||
Gross Profit | 1.76 | 2.88 | 9.32 | 14.7 | 23.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 10.1 | 12.9 | 25.1 | 32.7 | 47.8 |
Operating Profit | -6.14 | -5.5 | -9.56 | -8.91 | -13.5 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -6.2 | -5.69 | -9.84 | -9.13 | -14.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -6.2 | -5.69 | -9.86 | -9.15 | -14.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -6.2 | -5.69 | -9.86 | -9.15 | -14.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.2 | -5.69 | -9.86 | -9.15 | -14.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.106 | -0.086 | -0.133 | -0.118 | -0.181 |